High Density Lipoprotein Administration: A New Therapeutic Modality for the Treatment of Cardiovascular Diseases

E-ISSN： 1875-6107|5|4|321-333

ISSN： 1568-0134

Source： Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol.5, Iss.4, 2005-08, pp. : 321-333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of High-Density Lipoprotein Cholesterol in the Prevention and Possible Treatment of Cardiovascular Diseases

Current Molecular Medicine, Vol. 6, Iss. 5, 2006-08 ,pp. : 571-587

Bentham Science Publishers

Access to resources Recommend Favorite

Lipoprotein(a) is a Therapeutic Target for Cardiovascular Disease

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 12, Iss. 2, 2012-06 ,pp. : 118-121

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Application of Endothelial Progenitor Cells for Treatment of Cardiovascular Diseases

Current Stem Cell Research & Therapy, Vol. 9, Iss. 5, 2014-09 ,pp. : 401-414

Bentham Science Publishers

Access to resources Recommend Favorite

Increasing High-Density Lipoprotein Cholesterol Through Cholesteryl Ester Transfer Protein Inhibition: A Next Step in the Fight Against Cardiovascular Disease?

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, Iss. 6, 2005-12 ,pp. : 481-488

Bentham Science Publishers

Access to resources Recommend Favorite

Dietary Factors that Affect High Density Lipoprotein Concentrations

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 5, Iss. 4, 2005-08 ,pp. : 361-365

Bentham Science Publishers

Access to resources Recommend Favorite